The abstract is read at the publisher; the summary is JClub's.
A knobless fowl adenovirus type 1 fiber–fused soluble TRAIL variant, mut-FA1TLST, reduced liver tropism and enhanced antitumor activity of an oncolytic adenovirus in vitro and in vivo.
- Why it matters: Soluble TRAIL can be unstable and accumulates in the liver, limiting oncolytic adenovirus immunotherapy; improving targeting while preserving immune activation is needed.
- What they did: The team engineered mut-FA1TLST by fusing an optimized sTRAIL (FA1FT) with a knobless fiber motif from fowl adenovirus type 1, then tested structural design, genetic engineering, and activity in vitro and in vivo.
- The result: The capsid-modified oncolytic adenovirus expressing the optimized sTRAIL improved tumor targeting and antitumor efficacy and promoted CD4+ T cells, CD8+ T cells, and dendritic cell activation in the tumor microenvironment.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.